VERIFIEDMint Companies·16 Jun 2026neutral

Biocon eyes crown of world’s top insulin supplier amid rush for GLP-1

AI Summary

·Biocon is currently the third-largest insulin supplier globally by volume.
·The company has significantly invested in increasing its production capacity.
·Chairperson Kiran Mazumdar-Shaw highlighted the company's focus on insulin supply amidst the demand for GLP-1 drugs.